Skip to main content
. 2019 Dec 4;107(1):44–55. doi: 10.1002/bjs.11391

Table 4.

Outcome reporting in included studies

No. of studies reporting outcomes (n = 39) Range of rates reported (%)*
Adverse events
Device removal 27 0·5–8·3
Device erosion 8 0·1–1·2
Need for dilatation 22 2–67
Readmission to hospital within 30 days 13 1·3–5·4
Mortality 3 0
Clinical
DeMeester score 7
Manometry 4
Oesophageal pH testing 10
Oesophagogastroduodenoscopy 13
Barium swallow 7
Proton pump inhibitor use 25
Process
Duration of operation (min) 16 23–184
Duration of hospital stay (days) 13 0–3
Patient‐reported outcomes
GERD‐HRQL score 31
Other validated patient‐reported outcomes 7
Non‐validated patient‐reported outcome 5
Economic
Costs associated with device 1
*

Unless indicated otherwise;

values are median (range). GERD‐HRQL, gastro‐oesophageal reflux disease – health‐related quality of life.